This biomarker shows robust associations with several clinical (i.e., somatic symptoms, fatigue, depression severity, quality of life) and cognitive (i.e., psychomotor speed) outcomes and performs well in comparison to single inflammatory proteins, like IL-6, CRP, and sIL-6R. This evidence concerns the gene CRP and depressive disorder.